B6;B6D2-Tg(Pou2f3-Foxa2-ires-nEGFP)253Imt B6;B6D2-Tg(Pou2f3-Foxa2-ires-nEGFP)253Imt Carrier x Noncarrier [C57BL/6JJcl] Pou2f3 genomic DNA, Foxa2 cDNA, ires, large T antigen Nuclear Localization Signal, GFP cDNA, PolyA signal C57BL/6J (日本クレア) と交配 The RECIPIENIT of BIOLOGICAL RESOURCE must notify the content of the research to the DEPOSITOR and obtain a prior written consent on use of it from the DEPOSITOR. (Ichiro Matsumoto: ichiro.matsumoto1@gmail.com). The RECIPIENT of BIOLOGICAL RESOURCE agrees to include the DEPOSITOR and its colleagues as co-authors in first publication of the results obtained by use of the B|OLOGICAL RESOURCE. In publishing the research results obtained by use of the BTOLOGICAL RESOURCE, a citation of the following literature designated by the DEPOSITOR is requested. Nat Neurosci.2011(6):685-7. C (3-6 months) 松本 一朗 C(3〜6か月) 東京大学大学院生命科学研究科 / Monell Chemical Senses Center 松本一朗先生。B6D2F1受精卵へのインジェクション。 These transgenic mice express Foxa2a and nGFP genes under the control of the Pou2f3 promoter. Pou2f3遺伝子のプロモーター制御下でFoxa2および核移行GFPを発現するトランスジェニックマウス。 Ichiro MATSUMOTO 東京大学大学院生命科学研究科 / Monell Chemical Senses Center 松本一朗先生。 B6D2F1受精卵へのインジェクション。 B6-Pou2f3-Foxa2/GFP Tg#253 B6-Pou2f3-Foxa2/GFP Tg#253 These transgenic mice express Foxa2a and nGFP genes under the control of the Pou2f3 promoter. true 条件を付加する。<br>The RECIPIENIT of BIOLOGICAL RESOURCE must notify the content of the research to the DEPOSITOR and obtain a prior written consent on use of it from the DEPOSITOR. (Ichiro Matsumoto: ichiro.matsumoto1@gmail.com). The RECIPIENT of BIOLOGICAL RESOURCE agrees to include the DEPOSITOR and its colleagues as co-authors in first publication of the results obtained by use of the B|OLOGICAL RESOURCE. In publishing the research results obtained by use of the BTOLOGICAL RESOURCE, a citation of the following literature designated by the DEPOSITOR is requested. Nat Neurosci.2011(6):685-7. RBRC05247 Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li><li>GFP Transfer License (<A HREF="https://web.brc.riken.jp/ja/method/link/gfp_conclude">Japanese</A> / <A HREF="https://web.brc.riken.jp/en/method/link/gfp_conclude">English</A>)<br>Please fill in the <A HREF="https://web.brc.riken.jp/en/wp-content/uploads/form/gfp_schedule_a.doc">Schedule A</A>, and submit two signed copies to us together with two signed copies of RIKEN BRC's MTA. Please also read <A HREF="https://web.brc.riken.jp/en/wp-content/uploads/form/gfp_schedule_b.doc"> Schedule B</A>. </li></ol>